The HDLighthouse mission is to present and explain the latest research findings so that HD families can become proactive in their care, have hope for the future, and make good decisions in the present.

An Interview with Dr. Jan Nolta

A trial of mesenchymal stem cell is planned for the end of 2010.

Mesenchymal Stem Cells Repair Neurotoxin Damage in an Animal Model

Preclinical work supports the use of mesenchymal stem cells to treat neurodegenerative disorders.

Cogane

A new BDNF inducer enters the pipeline.

Track-HD Reports Baseline Findings

Clear differences were found among the control group, premanifest gene carriers, and those in early stages.

The Search for Genetic Modifiers

The search for genetic modifiers is an important part of the effort to find treatments.

The RCAN1 gene and HD

Overexpression of the RCAN1 gene may be a treatment for Huntington's Disease.

Axonal Transport Impaired in HD

Researchers have identified the mechanism by which axonal transport is impaired in neurons in HD.

Creatine and CoQ10

Creatine and CoQ10 have additive effects in the R6/2 mice

Rhes and the HD protein

Researchers at Johns Hopkins have discovered that a protein called rhes binds to the HD protein and causes toxicity

The RCAN1 gene and HD

Overexpression of the RCAN1 gene may be a treatment for Huntington's Disease.

Syndicate content